Neurodegeneration in histiocytoses might start in utero
暂无分享，去创建一个
[1] M. Rosenblum,et al. A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease , 2017, Nature.
[2] O. Abdel-Wahab,et al. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. , 2017, Blood.
[3] B. Rollins,et al. Histiocytoses: emerging neoplasia behind inflammation. , 2017, The Lancet. Oncology.
[4] Valérie Rigau,et al. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Christoph Bock,et al. Specification of tissue-resident macrophages during organogenesis , 2016, Science.
[6] K. Hoang-Xuan,et al. Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age , 2016, British journal of haematology.
[7] A. Fischer,et al. Revised Classification of Histiocytoses and Neoplasms of the Macrophage-dendritic Cell Lineages Histiocyte and Dendritic Cell Lineages the " L " (langerhans) Group , 2022 .
[8] V. Meignin,et al. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. , 2014, Blood.
[9] F. Geissmann,et al. Development and homeostasis of “resident” myeloid cells: The case of the microglia , 2013, Glia.